(PDN) Invesco FTSE RAFI Developed - Ratings and Ratios
Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US46138E7351 • Foreign Small/Mid Value
PDN: Small-cap Stocks, Mid-cap Stocks, International Stocks
The Invesco FTSE RAFI Developed Markets ex-U.S. Small-Mid ETF (NYSE ARCA: PDN) is designed to track the performance of small- and mid-capitalization companies in developed markets outside the United States. The fund invests at least 90% of its total assets in securities from the FTSE RAFI Developed Markets ex-U.S. Small-Mid Index, as well as American depositary receipts (ADRs) and global depositary receipts (GDRs) that represent securities in the index. The FTSE RAFI (Research Affiliates Fundamental Index) methodology selects companies based on fundamental metrics such as revenue, dividends, and book value, rather than market capitalization. This approach aims to provide exposure to undervalued companies with strong fundamental profiles.
The fund focuses on developed markets, excluding the U.S., and targets small- and mid-cap companies, which are typically defined as having market capitalizations below a certain threshold. The underlying index is maintained by FTSE, a leading global index provider, and is designed to reflect the performance of companies that meet specific size and fundamental criteria. The ETF is listed on the NYSE ARCA and is structured as a U.S.-domiciled investment vehicle, making it accessible to U.S. investors seeking international exposure.
Based on the provided data, here is a 3-month forecast for PDN:
From a technical perspective, PDN is currently trading near its 20-day SMA of 33.33, with a last price of 33.29. The 50-day SMA is slightly lower at 32.49, while the 200-day SMA is at 32.75. This suggests that the fund is in a neutral to slightly bullish short-term trend, with potential support near the 50-day SMA. The ATR of 0.30 indicates low volatility, which may persist in the near term.
From a fundamental perspective, the funds AUM of $401.79 million reflects moderate investor interest. Given the focus on small- and mid-cap companies in developed markets ex-U.S., PDN may benefit from improving economic conditions in these regions. However, currency fluctuations and geopolitical risks could impact performance. Average daily volume of 24,974 shares suggests moderate liquidity, which is typical for a niche ETF.
Overall, PDN is expected to remain range-bound in the next three months, with potential upside driven by strengthening fundamentals in international markets and downside limited by its low volatility profile. Investors seeking targeted exposure to small- and mid-cap companies in developed markets outside the U.S. may find PDN a suitable option.
Additional Sources for PDN ETF
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
PDN ETF Overview
Market Cap in USD | 319m |
Category | Foreign Small/Mid Value |
TER | 0.49% |
IPO / Inception | 2007-09-27 |
PDN ETF Ratings
Growth Rating | 35.1 |
Fundamental | - |
Dividend Rating | 66.0 |
Rel. Strength | 1.76 |
Analysts | - |
Fair Price Momentum | 34.30 USD |
Fair Price DCF | - |
PDN Dividends
Dividend Yield 12m | 3.37% |
Yield on Cost 5y | 5.14% |
Annual Growth 5y | 11.38% |
Payout Consistency | 87.6% |
PDN Growth Ratios
Growth Correlation 3m | 56.4% |
Growth Correlation 12m | 38.5% |
Growth Correlation 5y | 25.1% |
CAGR 5y | 9.80% |
CAGR/Max DD 5y | 0.29 |
Sharpe Ratio 12m | 0.33 |
Alpha | 3.46 |
Beta | 0.731 |
Volatility | 20.74% |
Current Volume | 8.9k |
Average Volume 20d | 20.7k |
As of May 10, 2025, the stock is trading at USD 35.85 with a total of 8,901 shares traded.
Over the past week, the price has changed by +1.00%, over one month by +10.16%, over three months by +8.81% and over the past year by +11.80%.
Partly, yes. Based on ValueRay Analyses, Invesco FTSE RAFI Developed (NYSE ARCA:PDN) is currently (May 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 35.06 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of PDN as of May 2025 is 34.30. This means that PDN is currently overvalued and has a potential downside of -4.32%.
Invesco FTSE RAFI Developed has no consensus analysts rating.
According to ValueRays Forecast Model, PDN Invesco FTSE RAFI Developed will be worth about 38.2 in May 2026. The stock is currently trading at 35.85. This means that the stock has a potential upside of +6.44%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 38.2 | 6.4% |